On 28 November 2025 the UKNSC made a draft recommendation to offer a targeted national prostate cancer screening programme to men with a confirmed BRCA1/2 gene variation every 2 years, from age 45 to age 61. It has launched a 12-week consultation on the draft proposal, closing on 20 February 2026.
Next steps
NHS England will now begin work to explore how prostate cancer screening for men could be delivered, in line with the final UKNSC recommendation, following the consultation, and subject to a Ministerial decision.
We expect the announcement to generate public interest in a potential new screening programme for prostate cancer, and the following lines are to help GP practices and NHS
Genomic Medicine Services answer questions from patients and the public.
